BioForce Nanosciences Holdings, Inc.
BFNH
$0.60
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -4.38% | -5.00% | 7.34% | 2.06% | 7.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.38% | -5.00% | 7.34% | 2.06% | 7.69% |
| Operating Income | 4.38% | 5.00% | -7.34% | -2.06% | -7.69% |
| Income Before Tax | 3.73% | 5.00% | -7.34% | -614.60% | -7.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.73% | 5.00% | -7.34% | -614.60% | -7.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.73% | 5.00% | -7.34% | -614.60% | -7.69% |
| EBIT | 4.38% | 5.00% | -7.34% | -2.06% | -7.69% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 16.67% | 16.67% | 5.13% | -544.44% | -7.69% |
| Normalized Basic EPS | 15.38% | 15.38% | 4.17% | 7.14% | -8.33% |
| EPS Diluted | 16.67% | 16.67% | 5.13% | -544.44% | -7.69% |
| Normalized Diluted EPS | 15.38% | 15.38% | 4.17% | 7.14% | -8.33% |
| Average Basic Shares Outstanding | 14.53% | 14.52% | 14.52% | 10.16% | 0.00% |
| Average Diluted Shares Outstanding | 14.53% | 14.52% | 14.52% | 10.16% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |